secwatch.observer — SEC 8-K summary
======================================

Issuer:     MACROGENICS INC (MGNX)
CIK:        0001125345
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001193125-24-247017
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MacroGenics CEO Scott Koenig to step down; search committee formed
------------------------------------------------------------------

- Scott Koenig to depart as President and CEO effective Feb 28, 2025; will resign from Board on same date.
- Separation includes 24 months salary continuation, target bonus, COBRA, and accelerated vesting of 50% of unvested equity.
- Continuing as advisor until Feb 28, 2030, with continued vesting of remaining unvested equity awards.
- Board formed special committee and retained Heidrick & Struggles to identify new CEO.
- Company highlights strong balance sheet and pipeline of antibody-based cancer therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1125345/000119312524247017/0001193125-24-247017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1125345/000119312524247017/d891583d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-247017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer